Umbilical cord blood transplantation for children with thalassemia and sickle cell disease.
about
Current and future alternative therapies for beta-thalassemia majorAlternative donor transplant of benign primary hematologic disordersUmbilical cord blood: an evolving stem cell source for sickle cell disease transplantsAdvances in unrelated and alternative donor hematopoietic cell transplantation for nonmalignant disordersWhat Unrelated Hematopoietic Stem Cell Transplantation in Thalassemia Taught us about Transplant ImmunogeneticsUpdate of hematopoietic cell transplantation for sickle cell diseaseGraft failure in the modern era of allogeneic hematopoietic SCT.Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.Umbilical cord blood banking: from personal donation to international public registries to global bioeconomyTherapeutic effects of induced pluripotent stem cells in chimeric mice with β-thalassemia.Characterization of transcription factor networks involved in umbilical cord blood CD34+ stem cells-derived erythropoiesis.Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group.Umbilical cord blood transplantation: the first 25 years and beyond.Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions.Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease.Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions.Awareness, Knowledge, and Acceptance of Haematopoietic Stem Cell Transplantation for Sickle Cell Anaemia in Nigeria.A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.Genetic strategies for the treatment of sickle cell anaemia.Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'.Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease.The expanding frontier of hematopoietic cell transplantation.Umbilical cord blood transplantation: review of factors affecting the hospitalized patient.The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease.Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts.Plasma-depleted versus red cell-reduced umbilical cord blood.Hematopoietic stem cell transplantation for sickle cell disease: state of the science.Blood and marrow transplantation for sickle cell disease: is less more?Sickle Cell Disease and Stroke: Diagnosis and Management.Unrelated donor stem cell transplantation for transfusion-dependent thalassemia.Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approaches.Cellular therapy for sickle cell diseaseTreosulfan-Based Conditioning Regimen in Sibling and Alternative Donor Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease.Cure for thalassemia major - from allogeneic hematopoietic stem cell transplantation to gene therapy.Traffic Light: prognosis-based eligibility for clinical trials of hematopoietic SCT in adults with sickle cell anemia.Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies.Knowledge and attitude of donating and using cord blood for transfusion among patients attending Nnamdi Azikiwe University Teaching Hospital, Nnewi, South East Nigeria.
P2860
Q26750906-CB31E1BD-A137-4EE4-A668-36E4F060F49AQ26823398-C40706C3-0287-4587-B8E9-9DCA1448BAEEQ26853559-0384343C-387D-4921-8C45-E7D048CC4781Q27022561-22F3BF23-9A9D-4C53-94FB-00DA375DD09EQ28075219-38081447-F080-4340-AE8B-6ED8FF1AF4ACQ28083007-5DFB7339-D444-4815-9D8B-8285C9A1B277Q33404733-928144EB-BE73-413B-BC82-63A1311447AEQ33558770-083E67FA-881C-4A7D-9F97-218E8F58B47BQ33800639-2DC8011D-223D-45BB-9D8A-13D6FA5D9AF0Q33978886-EB03AC90-DFC1-4023-9D29-63673AF166C0Q34166173-DAD3A740-5C3B-4623-98C7-05E69A6EFAA1Q34343785-7A0D7B93-B7FC-4764-BC79-61A579800764Q34344669-2324A8D6-A9E9-4390-98CB-D7D27C82C5C6Q34625467-8A778C51-9D3C-4386-B060-12BB6DEE483CQ36461789-61BD6BAB-9894-4D4D-8512-09DB30EC6C3AQ36745209-8AB1D199-0CDE-41BF-98B1-8E7B34CC99A9Q37154176-BC6D7F66-4EE9-411C-A471-56DE21F62719Q37329968-E900F394-F03F-4437-9CA3-E393B2353331Q37627281-45EB7CF0-91FA-4105-B09D-E30B564CFEB8Q37894826-27CFC92E-C8AD-4B85-A06A-E92F906B9E0DQ37969631-60787576-0D29-49AE-B11C-587282495D12Q38006433-EF64A088-C693-4CF8-B268-512A5A7A1E0FQ38032255-EBE2F8E4-EA42-4C04-9469-D18C3D137C1DQ38113482-7E2FC714-EAFA-4AA7-B8E9-56C9A5A6C470Q38176054-7000C5B6-532F-4728-A1F2-DF9B432AA589Q38207878-FFFC2C94-FE9A-4061-B27C-9D40E6F908A1Q38210864-A690543C-6392-44A4-963F-9832012B4708Q38247055-B8E014F0-4079-4B76-9583-50B31D4B5AA7Q38248808-6B6D252D-68BD-40E5-AF89-AC6F057DC6B0Q38732049-18861503-8131-4990-8F43-2EC940009ED6Q38783216-80566295-A5A0-426E-8375-BCCB6E47F387Q38851953-58E1410B-98E1-4CD7-A695-7CBEA00E3305Q38898163-62377DA4-7096-47EA-8A4B-115DE4A174E4Q38908093-0B7CEBF4-6C81-4CDD-9A46-E9E0297045F7Q39026510-7A14C604-2C36-4C01-959C-7DEAFAD8E05AQ40263947-D7853740-2E4E-4D66-B822-DD168DD0484DQ40411281-16F29278-C306-4D70-A265-FE135A58F602Q40582651-F760B392-61BC-42D0-B34D-3E721AFECDE3Q41010661-FFFD8708-B2F1-4B55-8A00-4B205E3BDCE0Q41831087-1DDCD4F5-CF1B-4A47-8108-0B2B5B198DC5
P2860
Umbilical cord blood transplantation for children with thalassemia and sickle cell disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Umbilical cord blood transplan ...... semia and sickle cell disease.
@ast
Umbilical cord blood transplan ...... semia and sickle cell disease.
@en
type
label
Umbilical cord blood transplan ...... semia and sickle cell disease.
@ast
Umbilical cord blood transplan ...... semia and sickle cell disease.
@en
prefLabel
Umbilical cord blood transplan ...... semia and sickle cell disease.
@ast
Umbilical cord blood transplan ...... semia and sickle cell disease.
@en
P2093
P2860
P1476
Umbilical cord blood transplan ...... semia and sickle cell disease.
@en
P2093
Anders Fasth
Andromachi Scaravadou
Annalisa Ruggeri
Center for International Blood and Marrow Transplant Research
Duncan Purtill
Eurocord Registry
Joanne Kurtzberg
John R Wingard
John Wagner
Karim Boudjedir
P2860
P304
P356
10.1016/J.BBMT.2011.01.012
P577
2011-01-28T00:00:00Z